help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, T. T.
Right arrow Articles by Hamilton, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, T. T.
Right arrow Articles by Hamilton, S. R.

American Journal of Pathology, Vol 150, 939-947, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps

TT Wu, B Rezai, A Rashid, MC Luce, MC Cayouette, C Kim, N Sani, L Mishra, CA Moskaluk, JH Yardley and SR Hamilton
Department of Pathology, Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland, USA.

Juvenile polyps are regarded as hamartomatous polyps and occur in sporadic and familial syndromic settings. There is increased risk of gastrointestinal neoplasia in patients with juvenile polyposis syndrome, but the molecular mechanisms are not known. We therefore studied 78 colorectal juvenile polyposis from 12 patients with juvenile polyps syndrome and 34 sporadic juvenile polyps for epithelial dysplasia and genetic changes associated with colorectal neoplasia. Dysplasia occurred in 31% of syndromic juvenile polyps but not in sporadic juvenile polyps (P < 0.0001). Topographic control of proliferation and expression of the cyclin-dependent kinase inhibitor p21(WAFI/CIP1) seen in native colorectal epithelium was lost in 79% of dysplastic juvenile polyps and in 8% of nondysplastic juvenile polyps (P < 0.000001). Somatic mutations in the adenomatous polyposis coli (APC) gene were demonstrated in 50% of dysplastic juvenile polyps (3 of 6) but not in any of 16 juvenile polyps without dysplasia (P = 0.01). Both sporadic and syndromic juvenile polyps had K-ras mutations (14%) and there was no relationship to dysplasia. p53 gene product overexpression identified by immunohistochemical staining occurred rarely in dysplastic juvenile polyps (2 of 24, 8%). Our results indicate that the multiple genetic alterations involved in usual colorectal neoplasia also play a role in neoplastic transformation of juvenile polyps, predominantly in juvenile polyposis syndrome.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
S. C. C. Wong, E. S. F. Lo, K. C. Lee, J. K. C. Chan, and W. L. W. Hsiao
Prognostic and Diagnostic Significance of {beta}-Catenin Nuclear Immunostaining in Colorectal Cancer
Clin. Cancer Res., February 15, 2004; 10(4): 1401 - 1408.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. M. De Marzo, V. L. Marchi, E. S. Yang, R. Veeraswamy, X. Lin, and W. G. Nelson
Abnormal Regulation of DNA Methyltransferase Expression during Colorectal Carcinogenesis
Cancer Res., August 1, 1999; 59(16): 3855 - 3860.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
Z.-J. Wang, F. Taylor, M. Churchman, G. Norbury, and I. Tomlinson
Genetic Pathways of Colorectal Carcinogenesis Rarely Involve the PTEN and LKB1 Genes Outside the Inherited Hamartoma Syndromes
Am. J. Pathol., August 1, 1998; 153(2): 363 - 366.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.